Provider prompts vs usual practice
Uptake of seasonal influenza vaccineb · healthcare workers
1 finding from 1 review
- no estimate extracted2 studies · 1439 participantsModerate
Findings
What do systematic reviews say?
72 questions · 72 findings · 12 reviews
No studies found 13 · 18.1%GRADE not reported 0 · 0%Very low 7 · 9.7%Low 21 · 29.2%Moderate 25 · 34.7%High 6 · 8.3%
Intervention not reported
Incidence of diphtheria, tetanus, pertussis, Haemophilus influenzae type b (Hib) (not measured) · infants aged approximately 2 to 6 months undergoing vaccination in the anterolateral thigh with a DTwP‐Hib vaccine
The review found no eligible studies for this question.
1 finding from 1 review
- Needle size for vaccination procedures in children and adolescents 2018 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found
Intervention not reported
Incidence of diphtheria, tetanus, pertussis, Haemophilus influenzae type b (Hib) (not measured) · infants aged approximately 2 to 6 months undergoing vaccination in the anterolateral thigh with a DTwP combination vaccine
The review found no eligible studies for this question.
1 finding from 1 review
- Needle size for vaccination procedures in children and adolescents 2018 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found
Intervention not reported
2d. Adequate immune response (seroprotection) against Haemophilus influenzae type b disease (surrogate outcome) · infants aged approximately 2 to 6 months undergoing vaccination in the anterolateral thigh with a DTwP combination vaccine
The intervention showed no clear difference in 2d. Adequate immune response (seroprotection) against Haemophilus… (moderate certainty).
1 finding from 1 review
- Needle size for vaccination procedures in children and adolescents 2018 · Cochrane Headline outcomes onlyRR 1.03 [0.96, 1.11]1 study · 414 participantsModerate
Intervention not reported
Incidence of diphtheria, tetanus, pertussis, Haemophilus influenzae type b (Hib) (not measured) · infants aged approximately 2 to 6 months undergoing vaccination in the anterolateral thigh with a DTwP‐Hib vaccine
The review found no eligible studies for this question.
1 finding from 1 review
- Needle size for vaccination procedures in children and adolescents 2018 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found
Intervention not reported
2d. Adequate immune response (seroprotection) against Haemophilus influenzae type b disease (surrogate outcome) · infants aged approximately 2 to 6 months undergoing vaccination in the anterolateral thigh with a DTwP‐Hib vaccine
The intervention showed no clear difference in 2d. Adequate immune response (seroprotection) against Haemophilus… (moderate certainty).
1 finding from 1 review
- Needle size for vaccination procedures in children and adolescents 2018 · Cochrane Headline outcomes onlyRR 1.06 [0.97, 1.16]1 study · 402 participantsModerate
Intervention not reported
2d. Adequate immune response (seroprotection) against Haemophilus influenzae type b disease (surrogate outcome) · infants aged approximately 2 to 6 months undergoing vaccination in the anterolateral thigh with a DTwP‐Hib vaccine
The intervention probably leads to higher 2d. Adequate immune response (seroprotection) against Haemophilus… (moderate certainty).
1 finding from 1 review
- Needle size for vaccination procedures in children and adolescents 2018 · Cochrane Headline outcomes onlyRR 1.1 [1.01, 1.2]1 study · 400 participantsModerate
Tetanus toxoid vs influenza vaccine
Neonatal tetanus deaths ‐ 1 dose · women aged between 13 and 45 years.
Tetanus toxoid showed no clear difference in neonatal tetanus deaths ‐ 1 dose compared with influenza vaccine (low certainty).
1 finding from 1 review
- RR 0.57 [0.26, 1.24]1 study · 494 participantsLow
Tetanus toxoid vs influenza vaccine
Neonatal tetanus deaths ‐ 2 or 3 doses · women aged between 13 and 45 years.
Tetanus toxoid probably leads to lower neonatal tetanus deaths ‐ 2 or 3 doses compared with influenza vaccine (moderate certainty).
1 finding from 1 review
- RR 0.02 [0, 0.3]1 study · 688 participantsModerate
Tetanus toxoid vs influenza vaccine
All causes of deaths ‐ 1 dose · women aged between 13 and 45 years.
Tetanus toxoid showed no clear difference in all causes of deaths ‐ 1 dose compared with influenza vaccine (low certainty).
1 finding from 1 review
- RR 1.08 [0.65, 1.79]1 study · 494 participantsLow
Tetanus toxoid vs influenza vaccine
All causes of deaths ‐ 2 or 3 doses · women aged between 13 and 45 years.
Tetanus toxoid probably leads to lower all causes of deaths ‐ 2 or 3 doses compared with influenza vaccine (moderate certainty).
1 finding from 1 review
- RR 0.31 [0.17, 0.55]1 study · 688 participantsModerate
Tetanus toxoid vs influenza vaccine
Neonatal tetanus cases ‐ Any dose · women aged between 13 and 45 years.
Tetanus toxoid probably leads to lower neonatal tetanus cases ‐ Any dose compared with influenza vaccine (moderate certainty).
1 finding from 1 review
- RR 0.2 [0.1, 0.4]1 study · 1182 participantsModerate